NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE134191 Query DataSets for GSE134191
Status Public on Jul 01, 2022
Title Gene expression profiling of tumor-infiltrating CD45+CD8+ cells and CD45- tumor cells of tumor bearing mice treated with metformin or anti-PD-1 Ab or both
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary B16 Mouse melanoma cells (MO5) grow in syngeneic C57BL/6 mice. Anti-PD-1 Ab as an Immunecheck point inhibitor and/or metformin were administered on day 7 after tumor inoculation to mice. The tumor growth was decreased by either anti-PD-1 Ab or metformin treatment. Anti- tumor effect was more pronounced by the combination therapy of anti-PD-1 Ab and metformin. The mechanism underlying the superior effect of the combination therapy to mono-therapies were investigated by RNA sequencing of tumor infiltrating CD8+ cells (CD8TILs) and tumor cells. As a result, CD8TILs with the combination therapy was found to express IFNg and GzmB and to activate IRF1/8, STAT1/2, NFkB, TBX21. Moreover, tumor cells were found to activate IRF1/8, STAT1/2, NFkB, indicating that tumor cells sharply responded to IFNg produced from CD8TILs. The IFNg was also found to downregulate metabolism both glycolysis and oxidative phosphorylation (OxPhos) of tumor cells, while it upregulates metabolism of CD8T cells. Collectively, the metabolic competition between CD8TILs and tumor cells was found to shift to the advantage of CD8TILs over tumor cells, resulting in the strong inhibition of tumor growth by the combination therapy of anti-PD-1 Ab and metformin.
 
Overall design Examination of CD8TILs and tumor cells of mice treated with either anti-PD-1 Ab or metformin or both.

Note: The GSE134191 and Sample metadata were updated on April 05, 2023.
 
Contributor(s) Nishida M, Udono H, Ogawa T, Shiroguchi K
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Jul 12, 2019
Last update date Apr 05, 2023
Contact name TAISAKU OGAWA
E-mail(s) taisaku.ogawa@riken.jp
Organization name RIKEN
Street address 6-2-3 Furuedai
City Suita
State/province Osaka
ZIP/Postal code 565-0874
Country Japan
 
Platforms (1)
GPL16417 Illumina MiSeq (Mus musculus)
Samples (24)
GSM3938596 CD8TIC_none_1
GSM3938597 CD8TIC_none_2
GSM3938598 CD8TIC_none_3
Relations
BioProject PRJNA554254
SRA SRP214434

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE134191_NormalizedGeneExpression.txt.gz 794.6 Kb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap